항암 화학요법을 받는 혈액종양 환자의 피로와 우울의 관계

Relationship between Fatigue and Depression in Patients with Hemato-Malignancy receiving Chemotherapy

Purpose: The purpose of this study was to identify the relationship of fatigue and depression in patients with hemato-malignancy receiving chemotherapy. Methods: The data were collected from December 2005 to November 2006. Study objects were recruited from 4 university hospital in B and U city. Fatigue and depression were measured using the Cancer Fatigue Scale and the Revised Zung's Self-rating Depression Scale, respectively. Results: 1) The mean score of fatigue was $64.64{\pm}21.58$. The mean score of depression was $41.28{\pm}7.62$. 2) The fatigue score was significantly different with age, employment status, and present pain. 3) The depression score was signigicant different by the payment, diet, and present pain. 4) There was a moderate positive correlation between depression and fatigue. Conclusions: Patients with hemato-malignancy receiving chemotherapy experience in fatigue. Decrease in fatigue are associated with decreases in depression. Therefore, nurses must provide planned nursing intervention to reduce fatigue and depression in patients with hemato-malignancy.